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S U M M A R Y
We report the ﬁrst case of acute meningitis caused by a rare, atypical pathogen. An 11-month-old infant
was admitted to hospital with clinical symptoms typical of acutemeningitis. Cerebrospinal ﬂuid analysis
revealed an elevated neutrophil cell count and high proteins. Microbiological examination of the
ﬂuid conﬁrmed an atypical cause of meningitis – Staphylococcus intermedius. Antibiotic therapy with
cefotaxime was successful and the child made a full recovery.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Acute bacterial meningitis is one of the most severe and feared
infectious diseases of childhood with high risk of neurological
consequences in case of delayed treatment (epilepsy, mental
retardation, sensorineural deafness, etc.). The most 3 common
etiologic agents are Haemophilus inﬂuenzae type b (Hib),
Streptococcus pneumoniae and Neisseria meningitides, which
are responsible for 90% of reported cases of acute bacterial
meningitis in infants and children older than 4 months. Besides
this, there are only a few reports in the literature describing the
cases of bacterial meningitis caused by atypical or rare microbio-
logical agenses.
2. Case report
An 11-month-old boy was admitted to the pediatric depart-
ment of the regional hospital with persisting fever. His prenatal
and perinatal history was normal. At the age of 6 months he had
experienced an episode of obstructive bronchitis of viral etiology
according to serological and inﬂammatory parameters, fromwhich
he had recovered. This respiratory infection did not leave any
important changes in the patient’s immune system. His social
history was also unremarkable. The family lived in a house in the
countryside. The parents did not suffer from any infectious or non-
infectious diseases. They kept a dog outside of the house, but there* Corresponding author. Tel.: +421 43 4203 254; fax: +421 43 422 26 78.
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history of dog bite. They did not have any other domestic animals
or pets.
The child’s present complaints had started 3 days before
examination in the hospital. The parents reported a high body
temperature (up to 40 8C) with poor response to antipyretic
medication, apathy, and dyspepsia, followed by nausea and
vomiting on the second day. No clinical signs of acute respiratory
or urogenital infection were observed at admission. Neurologi-
cally, typical meningeal symptoms were present (apathy, nausea,
vomiting, headache). On laboratory testing, elevated inﬂamma-
tory activity was noticed: white blood cell count of 13.0  109/l
with neutrophilia, erythrocyte sedimentation rate (Westergren
method) of 122 mm/1st h, moderate thrombocytopenia of
93.0  109/l, and elevated C-reactive protein (CRP). Taking into
account the clinical symptoms together with the laboratory
ﬁndings, the child was transferred to the pediatric intensive care
unit (PICU) of the Department of Pediatrics of Martin’s University
Hospital. On admission, the childwas febrile (39.8 8C), had nausea
andheadache, and became apathic and somnolent (Glasgow coma
scale index was 12 points, with reactions provoked by verbal and
contact stimuli). Upper and lower meningeal signs were positive.
No clinical signs of acute respiratory, gastrointestinal, or
urogenital infections were present. New laboratory examinations
showed an erythrocyte sedimentation rate of 120 mm/1st h, an
elevated white blood cell count of 17.0  109/l (normal value
according to the patient’s age: 4.0–12.0  109/l) with neutrophi-
lia, thrombocytopenia of 96  109/l (normal value according to
the patient’s age: 170–550  109/l), and increased non-speciﬁc
inﬂammatorymarkers (CRP 2.2 mg/dl (normal value:<0.6 mg/dl)ses. Published by Elsevier Ltd. All rights reserved.
Table 1
Minimum inhibitory concentrations of antibiotics against the isolated Staphylococ-
cus intermedius (mg/ml)
Antibiotic MIC Antibiotic MIC
Ampicillin >32 Cephalothin 0.250
Ampicillin + sulbactam 0.250 Ciproﬂoxacin 0.120
Oxacillin 0.125 Rifampin 0.050
Erythromycin 0.120 Vancomycin 1.000
Tetracycline 0.250 Teicoplanin 1.000
Linezolid 0.500 Clindamycin 0.050
Co-trimoxazole 2.000 Piperacillin >128
Cefotaxime 0.250 Gentamicin 0.250
MIC, minimum inhibitory concentration.
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Microbiological examination of rectal, nasal, and tonsil swabswas
completely negative (normal microﬂora of the upper airways and
gastrointestinal tract), without ﬁndings of an invasive microor-
ganism. Due to the laboratory ﬁndings and the patient’s
neurological status, a lumbar puncture was indicated and
performed immediately after admission to our department.
Cerebrospinal ﬂuid (CSF) analysis revealed the following: elevat-
ed proteins (1.2 g/l; normal value:<0.49 g/l), normal glucose (4.0
mmol/l), and normal chlorides (125 mmol/l). Cytological exami-
nation of the CSF showed a massively increased neutrophil cell
count (54  106 cells/l), normal lymphocyte cell count
(1  106 cells/l), and rare erythrocytes. Intravenous empirical
therapy for bacterialmeningitiswith cefotaxime (200 mg/kg body
weight/day) was started immediately. Microbiological examina-
tion of the CSF detected Gram-positive cocci. White, entire,
glistening microbial colonies were isolated on blood and
MacConkey agar. The colonies were coagulase-, pyrrolidonyl-
arylamidase-, and o-nitrophenyl-b-D-galactopyranoside-posi-
tive. The laboratory characteristics of the isolated bacterial
colonies suggested the presence of Staphylococcus intermedius.
The National Reference Laboratory of Microbiology in Prague
conﬁrmed the presence of this rare human pathogen in the CSF
through 16S rRNA gene sequence analysis. A complete suscepti-
bility survey of the isolated S. intermedius was undertaken;
minimum inhibitory concentration values (mg/ml) are listed in
the Table 1.
Fever continued for 3 days following the initiation of
cefotaxime therapy, but the patient’s neurological status improved
rapidly within 2 days of antimicrobial and symptomatic therapy.
The minimum inhibitory concentrations obtained and the culture
susceptibility examinations supported the use of cefotaxime
treatment. Antibiotic therapy was continued for 14 days. Control
laboratory examinations demonstrated a decrease in non-speciﬁc
inﬂammatory activity: erythrocyte sedimentation rate 25 mm/1st
h and 60 mm/2nd h, white blood cell count 7.11  109/l,
thrombocytes 425  109/l, and negativity of CRP and mucopro-
teins. Control analysis of CSF after treatment showed a normal
protein level (0.45 g/l), normal glucose (3.7 mmol/l), normal
chlorides (115 mmol/l), and cytologically normal neutrophil
(13.10  106 cells/l) and lymphocyte (3.10  106 cells/l) cell
counts. Culture of a CSF control specimen was sterile. The patient’s
neurological status was normal, without any signs of peripheral or
central neuropathy. Results of electroencephalography were
normal. Consequently, to exclude a possible focal infection of
the central nervous system, we performed a computed tomogra-
phy scan of the brain, which revealed normal, physiological
ﬁndings without any focal changes in the brain tissue. However,
from the immunological point of view, laboratory signs of mild
secondary combined immunodeﬁciency (decreased T-helper
lymphocyte absolute count together with hypogammaglobuline-
mia) were present; after one month these parameters were also
within the normal ranges.3. Discussion
S. intermedius is a coagulase-positive zoonotic organism found
in pigeons, dogs, foxes, cats, mink, and horses. Initially, all
coagulase-positive staphylococci were identiﬁed as Staphylococcus
aureus. In 1976, Ha´jek identiﬁed a new group of such microorgan-
isms called S. intermedius, previously identiﬁed as S. aureus
biotypes E and F.1 This species possesses some phenotypic
properties of S. aureus and also some characteristics of Staphylo-
coccus epidermidis. The identiﬁcation of S. intermedius is, however,
difﬁcult. It grows well on blood and MacConkey agars incubated
under aerobic conditions at 35 8C. After 24 h of incubation under
these conditions, the isolates formwhite, entire, convex, glistening
colonies, 5–6 mm in diameter, surrounded by a zone of b-
hemolysis on blood agar. S. intermedius is coagulase-, pyrrolidonyl-
arylamidase–, and o-nitrophenyl-b-D-galactopyranoside positive
and hydrolyses urea. Exact molecular identiﬁcation is performed
by 16S rRNA gene sequencing PCR analysis (ﬁrst 500 bp).2
S. intermedius is a common commensal of the oral, nasal, and
skin microﬂora in healthy dogs. In humans, it is considered an
invasive zoonotic pathogen and has often been isolated from
canine-inﬂicted wounds.3 The isolation from non-canine-inﬂicted
wounds is extremely rare in humans. Therefore, the direct search
for possible anamnestic contact with animals is necessary in
patients with a suspected S. intermedius infection. According to the
data available in the literature, this rare pathogen has been isolated
from infected varicose ulcers in two elderly patients and from an
infected suture line in a 13-year-old boy; all of these patients had
had previous contact with a dog.3 Pottumarthy et al.2 reported two
cases of non-canine-inﬂicted S. intermediuswound infections from
two separate hospitals, which occurred over a period of 8 months.
There was no previous contact with dogs. Both isolates were
initially misidentiﬁed and reported as methicillin-resistant S.
aureus (MRSA).2
According to the literature, S. intermedius has also been isolated
in the absence of canine- and non-canine-inﬂicted wounds. Some
authors have reported cases of immunocompromised patients
with infections caused by S. intermedius without anamnestic data
of previous contact with animals. This pathogen was isolated from
the blood of an HIV-positive patient with acute endocarditis,4 from
a nasal swab in an older woman with chronic renal insufﬁciency
undergoing ambulatory peritoneal dialysis,5 from blood culture in
a patient with catheter-related bacteremia,6 and from pleural
effusion in a man after heart transplantation.5 S. intermedius
isolation from the CSF or brain tissue is extremely rare. The blood–
brain barrier (hematoencephalic barrier) is a highly selective
membrane, which protects the human brain against various
pathogenic stimuli (toxins, microorganisms, etc.), and together
with the skull and other membranes covering the brain, creates an
effective complex protection for the brain tissue. When pathogens
penetrate these barriers, the clinical symptoms of a central nervous
system infection develop very rapidly. The clinical course of these
infections is usually severe; appropriate antibiotic treatment is
required and determines the ﬁnal outcome in the patient. In the
literature, we could ﬁnd only one case report of CNS involvement –
a brain abscess caused by S. intermedius in an adult man.7
To our knowledge, this is the ﬁrst report of acute meningitis
caused by this rare zoonotic pathogen in the human. In our
pediatric patient, the diagnosis of acute bacterial meningitis was
suspected according to the clinical presentation and laboratory
ﬁndings, and this was conﬁrmed by CSF analysis. The ﬁnal
identiﬁcation of the causal pathogen – S. intermedius – was
performed in Prague. The child lives in the countrysidewhere there
is the potential for close contact with various domestic animals,
including dogs, cats and horses. The parents, however, excluded
possible contact with animals, and all the animals living with this
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was, therefore, not clearly identiﬁed. Empirical antibiotic treat-
ment of the meningitis with cefotaxime was successful and the
child made a complete recovery.
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